Search form
Search
contact us
Navigation
home
boards
Jobs
job ratings
cp wire
medtech news
pharmagather
catering
advertise
whistleblower info
pharmaceutical fraud
medical device | DME fraud
clinical lab fraud
False Claims Act
Legal Help
login/register
You are here
Home
» OncBioMune Announces Good News for Ph II Trial of Prostate Cancer Vaccine
OncBioMune Announces Good News for Ph II Trial of Prostate Cancer Vaccine
OncBioMune Announces Good News for Ph II Trial of Prostate Cancer Vaccine
Submitted by
CP Staff
on June 20, 2018 - 9:18am
Source:
CP Wire
News Tags:
OncBioMune
ProscaVax
prostate cancer
vaccines
clinical trials
Headline:
OncBioMune Announces Good News for Ph II Trial of Prostate Cancer Vaccine
snippet:
ProscaVax is OncBioMune’s lead immunotherapy platform candidate
Ph I trials led to PSA reductions in 3/4 of patients
Do Not Allow Advertisers to Use My Personal information
